Stocktoria
Intellia Therapeutics, Inc. NTLA
Intellia Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 9,597,607 | $214.8M | 8.25% |
| ARK Investment Management LLC | 14,509,247 | $186.0M | 12.47% |
| D. E. Shaw & Co., Inc. | 5,728,177 | $73.4M | 4.92% |
| TWO SIGMA INVESTMENTS, LP | 4,705,901 | $60.3M | 4.05% |
| CITADEL ADVISORS LLC | 1,117,641 | $14.3M | 0.96% |
| AQR CAPITAL MANAGEMENT LLC | 630,529 | $8.1M | 0.54% |
| Point72 Asset Management, L.P. | 297,011 | $3.8M | 0.26% |
| MILLENNIUM MANAGEMENT LLC | 70,559 | $904,566 | 0.06% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.